Authors


Jana Spes

Latest:

Quality Metrics and CMO Agreement

FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.


Silvia Rocchi

Latest:

Evaluating E&L Studies for Single-Use Systems

Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.


Gabriella Angiuoni

Latest:

Evaluating E&L Studies for Single-Use Systems

Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.


Irene Cecchini

Latest:

Evaluating E&L Studies for Single-Use Systems

Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.


Daniele Mastroianni

Latest:

Evaluating E&L Studies for Single-Use Systems

Extraction studies demonstrate approaches for evaluating single-use bio-pharmaceutical manufacturing materials.


Jason L. Drori

Latest:

The Powerful Lesson of the GSK–Whistleblower Case

Those at the top must walk the walk of uncompromising commitment to compliance


Alain Desgeorges, PhD

Latest:

Evaluation of a Single-Use Bioreactor for the Fed-Batch Production of a Monoclonal Antibody

Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.


Gil Roth

Latest:

CDMOs: New Administration, New Frontier

Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.


Peter J. Martin

Latest:

Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution

The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.


James D. Colandene

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.


W. Aaron Pruett

Latest:

Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution

The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.


Douglas P. Nesta

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.



Kevin E. Noonan

Latest:

Protecting Intellectual Property for COVID-19 Innovations

Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.



Zahra Shahrokh

Latest:

Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition Temperature

An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.



Angelo DePalma

Latest:

Reconciling Sensor Communication Gaps

Process controls get some upgrades to better reflect real-time conditions.


Thomas A. Little

Latest:

Statistical Approaches for Determining Comparability of Biosimilars

Correct organization and appropriate methods for demonstrating biosimilar comparability are important for supporting regulatory filings.


Balkrishen Bhat

Latest:

Perspectives in MicroRNA Therapeutics

The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.



Peifeng Hu

Latest:

Meningitis Vaccine Manufacturing: Fermentation Harvest Procedures Affect Purification

Careful analysis of an unusual precipitate identifies defects.




Vicky Qing XIA

Latest:

Staffing for China’s Rapidly Growing Biomanufacturing Industry

New study shows China biopharma companies face staffing shortages.


Fernanda Masri

Latest:

Downstream Processing for Cell-Based Therapies

For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.


Qasim A. Rafiq

Latest:

Downstream Processing for Cell-Based Therapies

For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.


Joseph Marks

Latest:

Improving Productivity to Drive Drug Discoveries to Patients

Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.


Erik Goormaghtigh

Latest:

FTIR Spectroscopy as a Multi-Parameter Analytical Tool

FTIR can successfully measure key characteristics of therapeutic proteins in a single step.


Allison Derenne

Latest:

FTIR Spectroscopy as a Multi-Parameter Analytical Tool

FTIR can successfully measure key characteristics of therapeutic proteins in a single step.

© 2025 MJH Life Sciences

All rights reserved.